≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

This is a non-core endpoint: only basic statistics are computed.

Benign neoplasm: Penis

Endpoint Browser

CD2_BENIGN_PENIS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

only males

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D29.0&
  • Hospital discharge: ICD-9 — 2221
  • Hospital discharge: ICD-8 — 2221
  • Cause of death: ICD-10 — D29.0&
  • Cause of death: ICD-9 — 2221
  • Cause of death: ICD-8 — 2221

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D29
Name in latin
Neoplasma benignum penis

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 68 - 68
Unadjusted period prevalence (%) 0.03 - 0.03
Median age at first event (years) 44.10 - 44.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
65
Matched controls
649
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
59.9
48
*
22210
ICD-8 Finland
Benign neoplasm of male genital organs, Penis
+∞
15.2
14
*
KGB00
NOMESCO Finland
Biopsy of penis
79.7
12.1
13
*
130
Kela drug reimbursment
Malignant tumour
+∞
10.7
10
*
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
13.9
10.0
17
16
KGH10
NOMESCO Finland
Operation for phimosis
11.3
7.2
13
14
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
6.3
6
*
M05BX04
ATC
denosumab; parenteral
+∞
6.3
6
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
6.3
6
*
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
37
3.72
3.53
1.3
1.2
—
—
—
0
0
12
39
3.52
3.27
2.1
2.5
0.2
0.2
g/l
0.20
12
33
7
14
5.44
2.80
3.4
1.4
—
—
—
0
0
7
16
4.75
2.55
3.0
3.1
—
—
—
0
0
23
127
2.23
2.31
4.0
2.7
—
—
—
0
0
29
181
2.05
2.11
2.0
2.0
108.8
90.0
pmol/l
0.86
20
91
43
313
2.02
2.01
7.2
3.3
—
—
—
0
0
16
82
2.24
1.89
4.4
2.6
—
—
—
0
0
34
232
1.93
1.88
4.2
3.0
0.0
0.0
estimate
—
7
40
26
162
1.98
1.86
7.9
6.4
—
—
—
0
0
12
56
2.39
1.73
1.2
1.6
—
—
—
0
0
6
19
3.36
1.70
1.5
1.4
—
—
—
0
0
7
25
3.00
1.70
4.0
3.5
—
—
—
0
0
20
117
2.00
1.69
1.2
1.3
—
—
—
0
0
21
126
1.96
1.65
2.4
1.4
—
—
—
0
0
7
28
2.67
1.49
1.9
7.6
24.2
25.0
mmol/l
—
7
28
12
60
2.21
1.49
1.9
1.9
—
—
—
0
0
33
236
1.77
1.48
5.8
4.1
0.0
0.0
estimate
—
7
40
33
238
1.75
1.43
4.3
3.0
0.0
0.0
estimate
—
7
37
14
76
2.06
1.42
1.4
2.2
—
—
—
0
0
26
176
1.77
1.39
3.9
3.0
—
—
—
0
0
11
58
2.07
1.20
2.1
3.4
2.3
1.5
mmol/l
0.35
11
39
29
210
1.66
1.19
4.4
10.5
1.1
1.3
inr
—
10
54
5
20
2.61
1.17
12.4
39.7
—
—
—
0
0
11
59
2.03
1.15
2.1
3.7
—
—
—
0
0
17
107
1.79
1.13
3.9
5.6
—
—
—
0
0
30
222
1.63
1.12
11.2
9.6
0.0
0.0
e9/l
0.00
25
178
10
53
2.04
1.08
1.1
1.4
—
323.1
titre
—
0
13
52
444
1.73
1.07
23.5
15.8
13.9
13.6
%
0.78
52
435
7
35
2.11
1.03
2.3
1.5
—
—
—
0
0
18
121
1.66
0.95
3.8
2.7
—
—
—
0
0
20
139
1.62
0.93
2.0
2.1
—
—
—
0
0
8
43
1.97
0.91
2.0
1.8
—
—
—
0
0
8
48
1.75
0.82
8.5
9.6
—
—
—
0
0
6
33
1.90
0.81
2.7
1.7
1.7
1.6
%
—
6
33
0
24
0.00
0.81
0.0
5.7
—
—
—
0
0
16
110
1.59
0.77
10.4
6.4
—
—
—
0
0
12
78
1.65
0.71
1.3
2.5
—
—
—
0
0
7
43
1.70
0.69
1.1
1.4
—
—
—
0
0
26
206
1.42
0.65
2.5
2.5
0.4
0.7
ug/l
3.18
18
135
8
50
1.68
0.64
9.1
18.8
86.3
94.1
%
—
8
50
22
173
1.40
0.56
5.0
4.8
11.2
12.5
mg/mmol
0.05
14
119
6
40
1.55
0.53
8.5
2.9
—
—
—
0
0
54
495
1.44
0.52
21.3
14.0
41.4
41.9
%
0.14
36
367
60
563
1.56
0.51
20.0
11.3
—
—
—
0
0
10
70
1.50
0.44
3.6
2.6
11.8
15.9
umol/l
—
10
62
8
59
1.40
0.43
1.8
1.2
—
—
—
0
0
0
15
0.00
0.42
0.0
1.8
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
5
34
1.51
0.41
12.4
11.2
0.4
0.7
%
—
5
34
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
18
145
1.33
0.39
6.8
3.9
—
—
—
0
0
20
165
1.30
0.37
3.8
3.6
90.1
446.4
mg/l
0.50
14
117
12
153
0.74
0.35
2.2
2.5
412.3
9717.2
umol/l
1.05
12
131
16
130
1.30
0.32
5.2
3.1
0.0
0.0
estimate
—
7
35
16
132
1.28
0.29
5.5
4.6
—
—
—
0
0
5
39
1.30
0.23
2.6
3.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
6
48
1.27
0.21
11.7
19.5
134.0
132.0
g/l
—
6
48
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
57
549
1.24
0.19
23.7
15.7
139.7
139.7
mmol/l
0.01
57
533
57
553
1.19
0.14
23.9
15.7
4.1
4.0
mmol/l
0.16
57
537
24
223
1.12
0.11
5.7
3.1
86.5
73.5
ng/l
0.09
17
158
39
378
1.07
0.06
3.8
4.0
—
—
—
0
0
54
539
1.01
0.00
21.0
12.2
23.8
25.8
mg/l
0.14
47
410
11
109
1.01
0.00
4.3
3.2
—
—
—
0
0
22
224
0.97
0.00
3.7
2.9
—
—
—
0
0
6
64
0.93
0.00
1.7
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
5
50
1.00
0.00
5.2
2.3
261.8
109.9
ug/g
—
5
40
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
0
7
0.00
0.00
0.0
13.3
—
616.1
—
0
7
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
5.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
90.6
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_PENIS_EXALLC – Benign neoplasm: Penis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).